Works matching DE "MULTIPLE myeloma"

Results: 5000

BCL2 inhibition for multiple myeloma and AL amyloidosis.

Published in:

British Journal of Haematology, 2025, v. 206, n. 5, p. 1285, doi. 10.1111/bjh.20046

By:

Cani, Lorenzo;
Gupta, Vikas A.;
Kaufman, Jonathan L.

Publication type:

Article

First relapse in older adults with multiple myeloma: Creating new pathways in uncharted territory.

Published in:

British Journal of Haematology, 2025, v. 206, n. 5, p. 1523, doi. 10.1111/bjh.20000

By:

Wildes, Tanya M.

Publication type:

Article

Iberdomide, ixazomib and dexamethasone in elderly patients with multiple myeloma at first relapse.

Published in:

British Journal of Haematology, 2025, v. 206, n. 5, p. 1366, doi. 10.1111/bjh.19978

By:

Touzeau, Cyrille;
Leleu, Xavier;
Tiab, Mourad;
Macro, Margaret;
Perrot, Aurore;
Gay, Julie;
Chateleix, Carine;
Moreau, Stéphane;
Karlin, Lionel;
Jacquet, Caroline;
Manier, Salomon;
Hulin, Cyrille;
Decaux, Olivier;
Richez, Valentine;
Chalopin, Thomas;
Mohty, Mohamad;
Orsini‐Piocelle, Frédérique;
Caillot, Denis;
Sonntag, Cécile;
Vignon, Marguerite

Publication type:

Article

Monoclonal Gammopathy of Undetermined Significance And Bone Disease: A Mini Review.

Published in:

Journal of Research & Practice on the Musculoskeletal System (JRPMS), 2025, v. 9, n. 1, p. 28, doi. 10.22540/JRPMS-09-028

By:

Sellina, Dimitra

Publication type:

Article

Publisher Correction: Predicting progression events in multiple myeloma from routine blood work.

Published in:

2025

By:

Ferle, Maximilian;
Grieb, Nora;
Kreuz, Markus;
Ader, Jonas;
Goldschmidt, Hartmut;
Mai, Elias K.;
Bertsch, Uta;
Platzbecker, Uwe;
Neumuth, Thomas;
Reiche, Kristin;
Oeser, Alexander;
Merz, Maximilian

Publication type:

Correction Notice

Predicting progression events in multiple myeloma from routine blood work.

Published in:

NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01636-9

By:

Ferle, Maximilian;
Grieb, Nora;
Kreuz, Markus;
Ader, Jonas;
Goldschmidt, Hartmut;
Mai, Elias K.;
Bertsch, Uta;
Platzbecker, Uwe;
Neumuth, Thomas;
Reiche, Kristin;
Oeser, Alexander;
Merz, Maximilian

Publication type:

Article

Cardiac Device-Related Infective Endocarditis Caused by Salmonella Infantis—Case Report and Review of Clinical and Epidemiologic Implications.

Published in:

Pathogens, 2025, v. 14, n. 5, p. 474, doi. 10.3390/pathogens14050474

By:

Doležalová, Kristína;
Soják, Lubomír;
Grigláková, Annamária;
Jurenka, Ján;
Sedlák, Martin;
Horniaková, Lucia;
Kromka, Peter;
Szántová, Mária;
Sabaka, Peter

Publication type:

Article

CXCR Family and Hematologic Malignancies in the Bone Marrow Microenvironment.

Published in:

Biomolecules (2218-273X), 2025, v. 15, n. 5, p. 716, doi. 10.3390/biom15050716

By:

Liu, Yanquan;
Tang, Huanwen

Publication type:

Article

Post-Translational Modifications in Multiple Myeloma: Mechanisms of Drug Resistance and Therapeutic Opportunities.

Published in:

Biomolecules (2218-273X), 2025, v. 15, n. 5, p. 702, doi. 10.3390/biom15050702

By:

Hu, Shuoyang;
Xu, Jirun;
Cui, Weiyan;
Jin, Haoran;
Wang, Xiaoyu;
Maimaitiyiming, Yasen

Publication type:

Article

FAM46C Expression Sensitizes Multiple Myeloma Cells to PF-543-Induced Cytotoxicity.

Published in:

Biomolecules (2218-273X), 2025, v. 15, n. 5, p. 623, doi. 10.3390/biom15050623

By:

Miluzio, Annarita;
De Grossi, Federica;
Mancino, Marilena;
Biffo, Stefano;
Manfrini, Nicola

Publication type:

Article

Supra-Physiological Levels of Magnesium Counteract the Inhibitory Effect of Zoledronate on RANKL-Dependent Osteoclastogenesis.

Published in:

Biology (2079-7737), 2025, v. 14, n. 5, p. 533, doi. 10.3390/biology14050533

By:

Caselli, Lorenzo;
De Pasquale, Lisa;
Palumbo, Rossella;
Ricchiuto, Silvia;
Montanari, Monica;
Rontauroli, Sebastiano;
Ottani, Alessandra;
Norfo, Ruggiero;
Zanocco-Marani, Tommaso;
Grande, Alexis

Publication type:

Article

Is Salvage Autologous Stem Cell Transplantation Still a Viable Treatment Option in Relapsed Myeloma Patients? †.

Published in:

Medicina (1010660X), 2025, v. 61, n. 5, p. 859, doi. 10.3390/medicina61050859

By:

Čemažar, Luka;
Škerget, Matevž;
Skopec, Barbara

Publication type:

Article

The first case of Teclistamab interference with serum electrophoresis and immunofixation.

Published in:

2025

By:

Kadkhoda, Kamran;
Faiman, Beth;
Valent, Jason;
Albahra, Samer;
Boyert, Nicole

Publication type:

Letter

Serum ferritin can serve as a biomarker for the prognosis and increased the prognostic predictive value of ISS/RISS in multiple myeloma patients.

Published in:

Biomarkers, 2025, v. 30, n. 3, p. 246, doi. 10.1080/1354750X.2025.2485142

By:

Dong, Mengmeng;
Zhang, Jinna;
Yang, Li;
Li, Yi;
He, Jingsong;
Cai, Zhen

Publication type:

Article

Effects of a Concurrent Mixed-Modality (Telerehabilitation and Face-to-Face) Exercise Rehabilitation Program in a Patient with Multiple Myeloma Prior to Spinal Cord Transplantation: A Case Study.

Published in:

Current Oncology, 2025, v. 32, n. 5, p. 282, doi. 10.3390/curroncol32050282

By:

Hernández-Sigüenza, Juan Carlos;
Blanco-Gimenez, Paula;
Baraja-Vegas, Luis;
López-Soler, Josep;
Falaguera-Vera, Francisco Javier;
Jaenada-Carrilero, Eloy;
Vicente-Mampel, Juan

Publication type:

Article

Real-World Treatment Patterns and Survival Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Treated with a Selinexor-Containing Triplet-Based Regimen.

Published in:

Current Oncology, 2025, v. 32, n. 5, p. 268, doi. 10.3390/curroncol32050268

By:

Whiteley, Andrew;
Ijioma, Stephen C.;
Ray, David;
Langerman, Spencer S.;
Hu, Ellen;
Pierre, Amy;
Mark, Tomer;
Yimer, Habte

Publication type:

Article

Focus sur un accompagnement à domicile des patients atteints de myélome multiple.

Published in:

2025

By:

Levard, Romain

Publication type:

Abstract

BLOOD TRANSFUSION MANAGEMENT FOR PATIENTS WITH MULTIPLE MYELOMA TREATED WITH ANTI-CD38 MONOCLONAL ANTIBODIES – CASE REPORTS.

Published in:

2024

By:

DINIĆ, Radovan;
BUJANDRIĆ, Nevenka;
GRUJIĆ, Jasmina

Publication type:

Case Study

Clinical and Epidemiological Insights into a Parainfluenza Virus Type 3 Outbreak in Multiple Myeloma Patients.

Published in:

Journal of Medical Virology, 2025, v. 97, n. 5, p. 1, doi. 10.1002/jmv.70411

By:

Timsit, Sarah;
Mellon, Guillaume;
Forgeard, Nathalie;
Mercier‐Delarue, Séverine;
Mahjoub, Nadia;
Euzen, Victor;
Harel, Stéphanie;
Elessa, Dikelele;
Osinski, Nathalie;
Diaz, Elise;
Royer, Bruno;
Arnulf, Bertrand;
Salmona, Maud;
Legoff, Jérôme

Publication type:

Article

Diagnostic Methods Used in Detecting Multiple Myeloma in Paleopathological Research—A Narrative Review.

Published in:

Heritage (2571-9408), 2025, v. 8, n. 5, p. 166, doi. 10.3390/heritage8050166

By:

Brawańska-Maśluch, Kinga;
Olchowy, Cyprian;
Mikita, Grzegorz;
Wanat, Marta;
Świątko, Ada;
Krotliński, Michał;
Byrska, Martyna;
Grzelak, Joanna;
Data, Krzysztof;
Dąbrowski, Paweł

Publication type:

Article

Epidemiology and approaches for management of relapsed and refractory multiple myeloma in Gulf Countries: a narrative review and insights from the Gulf multiple myeloma experts.

Published in:

Current Medical Research & Opinion, 2025, v. 41, n. 4, p. 593, doi. 10.1080/03007995.2025.2502125

By:

Alhuraiji, Ahmad;
Lal, Amar;
Al Mehairi, Amna;
Alam, Arif;
Mudawi, Deena;
Khan, Faraz;
Al Nabhani, Ibrahim;
El-Najjar, Inas;
AL-farsi, Khalil;
K Rana, Shabeeha;
Wagdy, Tharwat;
Yassin, Mohamed A.;
Rodríguez Otero, Paula;
Haddadin, Haya;
Aljabban, Ali

Publication type:

Article

Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.

Published in:

Oncology (08909091), 2013, v. 27, p. 1

By:

Wang, Michael;
Jie Cheng

Publication type:

Article

Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.

Published in:

Oncology (08909091), 2013, v. 27, p. 1

By:

Shah, Jatin J.

Publication type:

Article

Incidence and Management of Renal Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib: Page 2 of 2.

Published in:

Oncology (08909091), 2013, v. 27, p. 1

By:

Shah, Jatin J.

Publication type:

Article

Overview and Management of Cardiac and Pulmonary Adverse Events in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Single-Agent Carfilzomib.

Published in:

Oncology (08909091), 2013, v. 27, p. 1

By:

Wang, Michael;
Jie Cheng

Publication type:

Article

Managing Adverse Events of Multiple Myeloma and Anti--Multiple Myeloma Treatment: A Perspective on Carfilzomib.

Published in:

Oncology (08909091), 2013, v. 27, p. 1

By:

Siegel, David S.

Publication type:

Article

Non-Secretory Myeloma: A Clinician's Guide.

Published in:

Oncology (08909091), 2013, v. 27, n. 9, p. 924

By:

LONIAL, SAGAR;
KAUFMAN, JONATHAN L.

Publication type:

Article

Non-Secretory Myeloma: Clinical and Biologic Implications.

Published in:

Oncology (08909091), 2013, v. 27, n. 9, p. 932

By:

FONSECA, RAFAEL

Publication type:

Article

Non-Secretory Myeloma: One, Two, or More Entities?

Published in:

Oncology (08909091), 2013, v. 27, n. 9, p. 930

By:

DIMOPOULOS, MELETIOS A.;
KASTRITIS, EFSTATHIOS;
TERPOS, EVANGELOS

Publication type:

Article

Rare Myelomas: Sometimes When You Hear Hooves, It's a Zebra...

Published in:

Oncology (08909091), 2013, v. 27, n. 8, p. 808

By:

GENTILI, SILVIA;
LONIAL, SAGAR

Publication type:

Article

IgD and IgE Variants of Myeloma: Valuable Insights and Therapeutic Opportunities.

Published in:

Oncology (08909091), 2013, v. 27, n. 8, p. 803

By:

RICHARDSON, PAUL G.;
LAUBACH, JACOB;
PABA-PRADA, CLAUDIA;
ANDERSON, KENNETH C.

Publication type:

Article

Unusual Myelomas: A Review of IgD and IgE Variants.

Published in:

Oncology (08909091), 2013, v. 27, n. 8, p. 798

By:

PANDEY, SHIVLAL;
KYLE, ROBERT A.

Publication type:

Article

ANNOUNCING A NEW SERIES: Understanding Unusual Dysproteinemias.

Published in:

Oncology (08909091), 2013, v. 27, n. 8, p. 740

By:

ARMITAGE, JAMES O.

Publication type:

Article

Management of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM).

Published in:

Oncology (08909091), 2011, v. 25, n. 7, p. 578

By:

KYLE., ROBERT A.;
BUADI, FRANCIS;
RAJKUMAR, S. VINCENT

Publication type:

Article

MGUS and Smoldering Myeloma: the Most Prevalent of Plasma Cell Dyscrasias.

Published in:

Oncology (08909091), 2011, v. 25, n. 7, p. 594

By:

RICHARDSON, PAUL G.;
LAUBACH, JACOB;
MITSIADES, CONSTANTINE S.;
SCHLOSSMAN, ROBERT L.;
GHOBRIAL, IRENE M.;
MUNSHI, NIKHIL C.;
ANDERSON, KENNETH C.

Publication type:

Article

Multiple Myeloma Precursor Disease: Current Clinical and Epidemiological Insights and Future Opportunities.

Published in:

Oncology (08909091), 2011, v. 25, n. 7, p. 589

By:

LANDGREN, OLA;
KORDE, NEHA

Publication type:

Article

Up-Front Management of Multiple Myeloma.

Published in:

Oncology (08909091), 2010, p. 8

By:

LONIAL, SAGAR;
ANDERSON, KENNETH C.;
FONSECA, RAFAEL;
LOVE, NEIL

Publication type:

Article

Multiple Myeloma in the Elderly: When to Treat, When to Go to Transplant.

Published in:

Oncology (08909091), 2010, v. 24, n. 11, p. 992

By:

Harousseau, Jean-Luc

Publication type:

Article

Melphalan or No Melphalan: That Is the Question.

Published in:

Oncology (08909091), 2010, v. 24, n. 11, p. 1000

By:

Kaufman, Jonathan;
Lonial, Sagar

Publication type:

Article

The Treatment of Elderly Patients With Multiple Myeloma: Is More Better?

Published in:

Oncology (08909091), 2010, v. 24, n. 11, p. 1004

By:

Bensinger, William

Publication type:

Article

Solitary Extramedullary and Bone Plasmacytomas versus Multiple Myeloma with Extramedullary Manifestation.

Published in:

2010

By:

Nair, Bijay

Publication type:

Opinion

Bone Disease in Multiple Myeloma.

Published in:

Oncology (08909091), 2009, v. 23, p. 28

By:

Drake, Matthew T.

Publication type:

Article

Bone Biology and the Role of the RANK Ligand Pathway.

Published in:

Oncology (08909091), 2009, v. 23, p. 9

By:

Murthy, Rashmi K.;
Morrow, P. K.;
Theriault, Richard L.

Publication type:

Article

Treatment of Multiple Myeloma: Whence Truth Over Belief?

Published in:

Oncology (08909091), 2009, v. 23, n. 5, p. 420

By:

Kaufman, Jonathan;
Lonial, Sagar

Publication type:

Article

Maximizing the Clinical Benefit of Novel Therapies in Multiple Myeloma.

Published in:

Oncology (08909091), 2009, v. 23, n. 5, p. 415

By:

Laubach, Jacob;
Mitsiades, Constantine;
Anderson, Kenneth;
Richardson, Paul

Publication type:

Article

FDA Grants Priority Review for Bortezomib in Newly Diagnosed Multiple Myeloma.

Published in:: Oncology (08909091), 2008, v. 22, n. 2, p. 204
Publication type:: Article

Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75.

Published in:: Oncology (08909091), 2008, v. 22, n. 1, p. 87
Publication type:: Article

Liposomal Doxorubicin in Combination With Bortezomib for Relapsed or Refractory Multiple Myeloma.

Published in:

Oncology (08909091), 2007, v. 21, n. 12, p. 1503

By:

Yang-Min Ning;
Kun He;
Dagher, Ramzi;
Sridhara, Rajeshwari;
Farrell, Ann T.;
Justice, Robert;
Pazdur, Richard

Publication type:

Article

Multiple Myeloma Trial Stopped Early Due to Significant Efficacy Advantage of Bortezomib.

Published in:: Oncology (08909091), 2007, v. 21, n. 11, p. 1402
Publication type:: Article

Lenalidomide Data in Multiple Myeloma Patients Demonstrate Impressive Survival Benefit.

Published in:: Oncology (08909091), 2007, v. 21, n. 9, p. 1143
Publication type:: Article